Format

Send to

Choose Destination
Viruses. 2009 Dec;1(3):510-22. doi: 10.3390/v1030510. Epub 2009 Oct 22.

Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response.

Author information

1
University of Pennsylvania, Department of Pediatrics, Children's Hospital of Philadelphia, 34 Street and Civic Center Boulevard, Philadelphia, PA 19104-4399, USA; E-Mail: amishamish@gmail.com (A.C.S.).

Abstract

A virulent recombinant HSV lacking the diploid γ(1)34.5 gene (Δγ(1)34.5) have been investigated over the last two decades both for anti-tumor therapy and as vaccine vectors. The first generation vectors, while safe, are incapable of sustained replication in the majority of treated patients. An interferon inducible host antiviral kinase, protein kinase R (PKR), limits late viral protein synthesis and replication of Δγ(1)34.5 viruses. This review describes the development of new Δγ(1)34.5 vectors, through serial passage selection and direct viral genome engineering, which demonstrate selective PKR evasion in targeted cells and improved viral replication without restoring neurovirulence.

KEYWORDS:

PKR; oncolytic HSV; Δγ134.5

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center